Thromb Haemost 1999; 82(04): 1371-1373
DOI: 10.1055/s-0037-1614401
Letters to the Editor
Schattauer GmbH

Phenotypic Expression of Murine Hemophilia

E.-M. Muchitsch
1   From the Research Laboratories of Baxter Hyland Immuno, Vienna, Austria
,
P. L. Turecek
1   From the Research Laboratories of Baxter Hyland Immuno, Vienna, Austria
,
K. Zimmermann
1   From the Research Laboratories of Baxter Hyland Immuno, Vienna, Austria
,
L. Pichler
1   From the Research Laboratories of Baxter Hyland Immuno, Vienna, Austria
,
W. Auer
1   From the Research Laboratories of Baxter Hyland Immuno, Vienna, Austria
,
G. Richter
1   From the Research Laboratories of Baxter Hyland Immuno, Vienna, Austria
,
H. Gritsch
1   From the Research Laboratories of Baxter Hyland Immuno, Vienna, Austria
,
H. P. Schwarz
1   From the Research Laboratories of Baxter Hyland Immuno, Vienna, Austria
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 19. März 1999

Accepted after major revision 24. Mai 1999

Publikationsdatum:
08. Dezember 2017 (online)

 

 
  • References

  • 1 Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS. Hemostasis in the mouse (Mus muculus): A review. Thromb Haemost 1999; 81: 177-88.
  • 2 Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH. Targeted disruption of the mouse factor VIII gene: a model for hemophilia A. Nature Genetics 1995; 10: 119-21.
  • 3 Bi L, Sarkar R, Naas T, Lawler AM, Pain J, Shumaker SL, Bedian V, Kazazian HH. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 1996; 88: 3446-50.
  • 4 Busler DE, Li SW. Rapid screening of transgenic type II and type XI collagen knock-out mice with three-primer PCR. BioTechniques 1996; 21: 1002-4.
  • 5 Muchitsch EM, Turecek PL, Gritsch H, Pichler L, Schwarz HP. Factor VIII deficiency in knockout mice is associated with spontaneous bleeding. Thromb Haemost 1997 Suppl. 230. (PS-938).
  • 6 Turecek PL, Gritsch H, Richter G, Auer W, Pichler L, Schwarz HP. Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease. Thromb Haemost 1997; 77: 591-9.